mPharma, a pan-African healthcare technology company announced today the launch of their mutti Keep My Price Program, which focused on patients using chronic medications.

After a successful pilot, mPharma launched the program which aims to help patients access their medications at affordable prices in the face of price fluctuations in the market.

Economic lows have led to disruptions in supply chain systems which have, in turn, resulted in increasing prices.

Medication costs have increased by as much as 30% at the wholesale level and by as much as 50% at the retail level.

Hence, mPharma has created this mutti Keep My Price program to provide patients some price stability during these times.

Speaking at the launch of the program, Gregory Rockson, CEO of mPharma is quoted as saying “An Africa in good health requires that patients are able to adhere to their medication, and that emphasises the need for medication affordability.”

The mutti Keep My Price Program was piloted in Ghana earlier this year, allowing over 1,000 patients to enjoy a fixed price on their medications for three months.

Regardless of broader market price changes, patients who were enrolled during the pilot phase enjoyed price stability for three months.